The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Chlorophenethyl ((S)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)amino)propan-2-yl)carbamate ID: ALA4103451
PubChem CID: 137656755
Max Phase: Preclinical
Molecular Formula: C25H34ClN3O5
Molecular Weight: 492.02
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)OCCc1cccc(Cl)c1
Standard InChI: InChI=1S/C25H34ClN3O5/c26-20-8-4-7-18(13-20)10-12-34-25(33)29-22(14-17-5-2-1-3-6-17)24(32)28-21(16-30)15-19-9-11-27-23(19)31/h4,7-8,13,16-17,19,21-22H,1-3,5-6,9-12,14-15H2,(H,27,31)(H,28,32)(H,29,33)/t19-,21-,22-/m0/s1
Standard InChI Key: DIYFESMLIMIHAX-BVSLBCMMSA-N
Molfile:
RDKit 2D
34 36 0 0 0 0 0 0 0 0999 V2000
9.7511 -18.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0419 -18.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0419 -17.5190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7511 -19.5743 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4601 -18.3443 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3287 -18.7531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8824 -18.3442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1692 -18.7528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1693 -19.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7733 -20.9721 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9666 -20.8014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8825 -19.9868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6339 -19.6483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1860 -20.2588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3602 -21.3492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5957 -18.7527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7509 -17.1062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7509 -16.2849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4599 -15.8762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1691 -16.2848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1691 -17.1061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4601 -17.5189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6224 -18.3421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9133 -18.7484 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6251 -17.5250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2070 -18.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4979 -18.7438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7916 -18.3329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7968 -17.5184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0913 -17.1076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3813 -17.5139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3812 -18.3354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0873 -18.7425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6736 -18.7441 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 1
1 4 2 0
1 5 1 0
2 6 1 0
8 7 1 6
8 9 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
10 14 1 0
11 15 2 0
12 9 1 6
7 16 2 0
5 8 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
17 22 1 0
3 17 1 0
6 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
32 34 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 492.02Molecular Weight (Monoisotopic): 491.2187AlogP: 3.16#Rotatable Bonds: 11Polar Surface Area: 113.60Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.74CX Basic pKa: ┄CX LogP: 3.04CX LogD: 3.04Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.41Np Likeness Score: 0.09
References 1. Galasiti Kankanamalage AC, Kim Y, Rathnayake AD, Damalanka VC, Weerawarna PM, Doyle ST, Alsoudi AF, Dissanayake DMP, Lushington GH, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC.. (2017) Structure-based exploration and exploitation of the S4 subsite of norovirus 3CL protease in the design of potent and permeable inhibitors., 126 [PMID:27914364 ] [10.1016/j.ejmech.2016.11.027 ]